董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David L. Fischel | 男 | Chief Executive Officer and Chairman of the Board | 39 | 6.44万美元 | 25.50 | 2026-03-12 |
| Nathan Fischel | -- | Independent Director | -- | 20.00万美元 | 1393.51 | 2026-03-12 |
| Myriam J. Curet | -- | Independent Director | -- | 20.00万美元 | 未持股 | 2026-03-12 |
| Arun Menawat | -- | Independent Director | -- | 20.00万美元 | 56.93 | 2026-03-12 |
| Ross B. Levin | -- | Independent Director | -- | 20.00万美元 | 15.50 | 2026-03-12 |
| Nachum Shamir | -- | Independent Director | -- | 20.00万美元 | 未持股 | 2026-03-12 |
| David W. Benfer | 男 | Independent Director | 79 | 20.00万美元 | 46.33 | 2026-03-12 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David L. Fischel | 男 | Chief Executive Officer and Chairman of the Board | 39 | 6.44万美元 | 25.50 | 2026-03-12 |
| Kimberly R. Peery | 女 | Chief Financial Officer | 57 | 32.61万美元 | 24.01 | 2026-03-12 |
董事简历
中英对照 | 中文 | 英文- David L. Fischel
-
David L. Fischel，自2016年9月领导股权投资和积极战略计划以来，一直担任Stereotaxis的董事。他曾在DAFNA Capital Management，LLC担任医疗器械投资的负责人和投资组合经理十多年。在加入DAFNA Capital之前，他是医疗保健风险投资基金SCP Vitalife的研究分析师。菲舍尔以优异成绩在加州大学洛杉矶分校取得了应用数学学士学位，辅修了会计学，并在特拉维夫的巴伊兰大学获得了MBA学位。他是注册会计师、特许金融分析师和特许另类投资分析师。Fischel先生对Stereotaxis，Inc.业务、运营和战略的广泛了解，以及金融和医疗设备行业的经验，使他能够为董事会做出宝贵的贡献。
David L. Fischel has served as a director of Stereotaxis since leading the equity investment and positive strategic initiatives announced in September 2016. He has served for over ten years as Principal and portfolio manager for medical device investments at DAFNA Capital Management, LLC. Prior to joining DAFNA Capital, he was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst. - David L. Fischel，自2016年9月领导股权投资和积极战略计划以来，一直担任Stereotaxis的董事。他曾在DAFNA Capital Management，LLC担任医疗器械投资的负责人和投资组合经理十多年。在加入DAFNA Capital之前，他是医疗保健风险投资基金SCP Vitalife的研究分析师。菲舍尔以优异成绩在加州大学洛杉矶分校取得了应用数学学士学位，辅修了会计学，并在特拉维夫的巴伊兰大学获得了MBA学位。他是注册会计师、特许金融分析师和特许另类投资分析师。Fischel先生对Stereotaxis，Inc.业务、运营和战略的广泛了解，以及金融和医疗设备行业的经验，使他能够为董事会做出宝贵的贡献。
- David L. Fischel has served as a director of Stereotaxis since leading the equity investment and positive strategic initiatives announced in September 2016. He has served for over ten years as Principal and portfolio manager for medical device investments at DAFNA Capital Management, LLC. Prior to joining DAFNA Capital, he was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst.
- Nathan Fischel
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Myriam J. Curet
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Arun Menawat
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Ross B. Levin
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Nachum Shamir
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- David W. Benfer
-
David W. Benfer目前是为卫生保健提供者和供应商提供咨询服务的Benfer Group LLC的主席。另外，他是医疗和卫生服务咨询公司Advisors to Healthcare Suppliers的合伙人。Benfer先生从1999年到2009年担任位于康涅狄格州，纽黑文的Saint Raphael Healthcare System和the Hospital of Saint Raphael的总裁兼首席执行官。在此之前，他从1992年到1999年担任位于伊利诺斯州， 乔利埃特的Provena-Saint Joseph和Morris Health Network的总裁兼首席执行官。Benfer先生从1985年到1992年担任底特律Henry Ford Health System医院和城市事务（Hospital and Urban Affairs）的高级副总裁以及Henry Ford Hospital的首席执行官。他从1998年到1999年担任American College of Healthcare Executives （ACHE）的主席并从1992年到2000年在其理事会工作。Benfer先生于1981年被任命为ACHE的股东，从2003年到2008年在Catholic Health Association董事会工作。Benfer先生还担任私人金融机构的董事和私人医疗保健服务公司的董事长。他从Xavier University获得了工商管理硕士学位，在Wittenburg University获得工商管理学士学位。
David W. Benfer, currently serves as the chairman of The Benfer Group LLC, which provides advisory services to healthcare providers and suppliers. In addition, he serves as a partner in Advisors to Healthcare Suppliers, a healthcare and health services consulting firm. From 1999 to 2009 Mr. Benfer served as president and chief executive officer of Saint Raphael Healthcare System and the Hospital of Saint Raphael, New Haven, Connecticut. Prior to that, he was the president and chief executive officer of the Provena-Saint Joseph/Morris Health Network in Joliet, Illinois from 1992 to 1999. Mr. Benfer served as senior vice president for Hospital and Urban Affairs for the Henry Ford Health System in Detroit and chief executive officer of the Henry Ford Hospital from 1985 to 1992. He served as the chairman of the American College of Healthcare Executives ACHE from 1998 to 1999 and on its board of governors from 1992 to 2000. Mr. Benfer was named a Fellow of ACHE in 1981 and served on the board of the Catholic Health Association from 2003 until 2008. Mr. Benfer also serves as a director of a private financial institution and chairman of the board of a private healthcare service company. He earned his M.B.A. from Xavier University and his B.S.B.A. from Wittenburg University. - David W. Benfer目前是为卫生保健提供者和供应商提供咨询服务的Benfer Group LLC的主席。另外，他是医疗和卫生服务咨询公司Advisors to Healthcare Suppliers的合伙人。Benfer先生从1999年到2009年担任位于康涅狄格州，纽黑文的Saint Raphael Healthcare System和the Hospital of Saint Raphael的总裁兼首席执行官。在此之前，他从1992年到1999年担任位于伊利诺斯州， 乔利埃特的Provena-Saint Joseph和Morris Health Network的总裁兼首席执行官。Benfer先生从1985年到1992年担任底特律Henry Ford Health System医院和城市事务（Hospital and Urban Affairs）的高级副总裁以及Henry Ford Hospital的首席执行官。他从1998年到1999年担任American College of Healthcare Executives （ACHE）的主席并从1992年到2000年在其理事会工作。Benfer先生于1981年被任命为ACHE的股东，从2003年到2008年在Catholic Health Association董事会工作。Benfer先生还担任私人金融机构的董事和私人医疗保健服务公司的董事长。他从Xavier University获得了工商管理硕士学位，在Wittenburg University获得工商管理学士学位。
- David W. Benfer, currently serves as the chairman of The Benfer Group LLC, which provides advisory services to healthcare providers and suppliers. In addition, he serves as a partner in Advisors to Healthcare Suppliers, a healthcare and health services consulting firm. From 1999 to 2009 Mr. Benfer served as president and chief executive officer of Saint Raphael Healthcare System and the Hospital of Saint Raphael, New Haven, Connecticut. Prior to that, he was the president and chief executive officer of the Provena-Saint Joseph/Morris Health Network in Joliet, Illinois from 1992 to 1999. Mr. Benfer served as senior vice president for Hospital and Urban Affairs for the Henry Ford Health System in Detroit and chief executive officer of the Henry Ford Hospital from 1985 to 1992. He served as the chairman of the American College of Healthcare Executives ACHE from 1998 to 1999 and on its board of governors from 1992 to 2000. Mr. Benfer was named a Fellow of ACHE in 1981 and served on the board of the Catholic Health Association from 2003 until 2008. Mr. Benfer also serves as a director of a private financial institution and chairman of the board of a private healthcare service company. He earned his M.B.A. from Xavier University and his B.S.B.A. from Wittenburg University.
高管简历
中英对照 | 中文 | 英文- David L. Fischel
David L. Fischel，自2016年9月领导股权投资和积极战略计划以来，一直担任Stereotaxis的董事。他曾在DAFNA Capital Management，LLC担任医疗器械投资的负责人和投资组合经理十多年。在加入DAFNA Capital之前，他是医疗保健风险投资基金SCP Vitalife的研究分析师。菲舍尔以优异成绩在加州大学洛杉矶分校取得了应用数学学士学位，辅修了会计学，并在特拉维夫的巴伊兰大学获得了MBA学位。他是注册会计师、特许金融分析师和特许另类投资分析师。Fischel先生对Stereotaxis，Inc.业务、运营和战略的广泛了解，以及金融和医疗设备行业的经验，使他能够为董事会做出宝贵的贡献。
David L. Fischel has served as a director of Stereotaxis since leading the equity investment and positive strategic initiatives announced in September 2016. He has served for over ten years as Principal and portfolio manager for medical device investments at DAFNA Capital Management, LLC. Prior to joining DAFNA Capital, he was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst.- David L. Fischel，自2016年9月领导股权投资和积极战略计划以来，一直担任Stereotaxis的董事。他曾在DAFNA Capital Management，LLC担任医疗器械投资的负责人和投资组合经理十多年。在加入DAFNA Capital之前，他是医疗保健风险投资基金SCP Vitalife的研究分析师。菲舍尔以优异成绩在加州大学洛杉矶分校取得了应用数学学士学位，辅修了会计学，并在特拉维夫的巴伊兰大学获得了MBA学位。他是注册会计师、特许金融分析师和特许另类投资分析师。Fischel先生对Stereotaxis，Inc.业务、运营和战略的广泛了解，以及金融和医疗设备行业的经验，使他能够为董事会做出宝贵的贡献。
- David L. Fischel has served as a director of Stereotaxis since leading the equity investment and positive strategic initiatives announced in September 2016. He has served for over ten years as Principal and portfolio manager for medical device investments at DAFNA Capital Management, LLC. Prior to joining DAFNA Capital, he was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst.
- Kimberly R. Peery
金伯利·R·佩里于2019年10月被任命为首席财务官。她于2003年加入公司，担任过多个职位，职责不断增加，包括自2016年11月起担任财务和信息系统副总裁，并于2013年4月至2016年11月担任财务总监。在加入本公司之前，她曾在多家私营公司担任财务总监。Peery女士是一名注册会计师。
Kimberly R. Peery was appointed as the Chief Financial Officer in October 2019. She joined the Company in 2003 and has held vario positions of increasing responsibilities including Vice President of Finance and Information Systems since November 2016 and Controller from April 2013 to November 2016. Prior to joining the Company, she served as a controller at vario private companies. Ms. Peery is a Certified Public Accountant.- 金伯利·R·佩里于2019年10月被任命为首席财务官。她于2003年加入公司，担任过多个职位，职责不断增加，包括自2016年11月起担任财务和信息系统副总裁，并于2013年4月至2016年11月担任财务总监。在加入本公司之前，她曾在多家私营公司担任财务总监。Peery女士是一名注册会计师。
- Kimberly R. Peery was appointed as the Chief Financial Officer in October 2019. She joined the Company in 2003 and has held vario positions of increasing responsibilities including Vice President of Finance and Information Systems since November 2016 and Controller from April 2013 to November 2016. Prior to joining the Company, she served as a controller at vario private companies. Ms. Peery is a Certified Public Accountant.